Filing metadata

Accession number
0001415889-24-016192
Form type
Form 4
Filer
Aclaris Therapeutics, Inc.
CIK
CIK 1557746
Filed
Jun 10, 2024
Reporting period
Jun 06, 2024
Description
Insider transaction

Explore SEC Filings Hub